# Mucosal Healing Study in Crohn's Disease (CD)

> **NCT00297648** · PHASE3 · COMPLETED · sponsor: **UCB Pharma** · enrollment: 89 (actual)

## Conditions studied

- Crohn's Disease

## Interventions

- **BIOLOGICAL:** Certolizumab pegol

## Key facts

- **NCT ID:** NCT00297648
- **Lead sponsor:** UCB Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-02
- **Primary completion:** 2008-01
- **Final completion:** 2009-12
- **Target enrollment:** 89 (ACTUAL)
- **Last updated:** 2011-08-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00297648

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00297648, "Mucosal Healing Study in Crohn's Disease (CD)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00297648. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*